Gilbert Marks
Patrimonio netto: 454 395 $ in data 31/08/2026
Patrimonio netto: 454 395 $ in data 31/08/2026
Gilbert Lynn Marks currently serves as Office Director at Biomedical Advanced Research & Development Authority and as Independent Director at AN2 Therapeutics, Inc. since 2020.
Former positions include Chairman at Global Alliance for TB Drug Development from 2006 to 2018, Chairman-Cures Acceleration Network Review Board at National Center for Advancing Translational Sciences from 2016 to 2021, Director at Women Organized Against Rape from 2017 to 2021, Member-Scientific Review Board at MMV Medicines for Malaria Venture from 2020 to 2021, Senior Vice President-Research & Development at GlaxoSmithKline LLC from 1993 to 2017, and Vice President at Tunnell Government Services, Inc. from 2017 to 2021.
Education includes undergraduate studies at Auburn University and a doctorate from the University of South Alabama.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 10/07/2026 | 81.873 ( 0,22% ) | 454 395 $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| AN2 THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/02/2020 |
Biomedical Advanced Research & Development Authority | Corporate Officer/Principal | - |
| Società | Posizione | Fine |
|---|---|---|
Tunnell Government Services, Inc.
Tunnell Government Services, Inc. Miscellaneous Commercial ServicesCommercial Services Provides assistance for government agencies | Corporate Officer/Principal | 01/09/2021 |
MMV Medicines for Malaria Venture
MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services Develops antimalarial drugs | Corporate Officer/Principal | 01/09/2021 |
National Center for Advancing Translational Sciences
National Center for Advancing Translational Sciences National AgencyGovernment National agency | Corporate Officer/Principal | 01/01/2021 |
Women Organized Against Rape
Women Organized Against Rape Services to the Health IndustryHealth Services Women Organized Against Rape (WOAR) is an organization committed to eliminating sexual violence through free, trauma-informed services, prevention education, and advocacy. The private company is based in Philadelphia, PA. Established in the early 1970s, WOAR serves survivors of sexual assault, abuse, harassment, and trafficking regardless of when the trauma occurred or the survivor’s background. The organization offers a 24/7 crisis hotline, individual and group counseling, restorative justice programs, and bilingual services, notably in Spanish. WOAR employs evidence-based therapeutic approaches such as trauma-informed cognitive behavioral therapy and EMDR, and extends support to diverse communities including LGBTQIA+ and Latino populations. The organization engages in advocacy for legal reforms, community education, and justice alternatives, and partners with local government on safe nightlife certification programs. WOAR also provides specialized trainings for industries such as hospitality and entertainment to foster safe, inclusive environments. | Direttore/Membro del Consiglio | 01/01/2021 |
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Develops tuberculosis drugs | Presidente | 01/01/2018 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 10 |
|---|---|
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Develops tuberculosis drugs | Health Technology |
Auburn University
Auburn University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of South Alabama
University of South Alabama Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MMV Medicines for Malaria Venture
MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services Develops antimalarial drugs | Commercial Services |
Women Organized Against Rape
Women Organized Against Rape Services to the Health IndustryHealth Services Women Organized Against Rape (WOAR) is an organization committed to eliminating sexual violence through free, trauma-informed services, prevention education, and advocacy. The private company is based in Philadelphia, PA. Established in the early 1970s, WOAR serves survivors of sexual assault, abuse, harassment, and trafficking regardless of when the trauma occurred or the survivor’s background. The organization offers a 24/7 crisis hotline, individual and group counseling, restorative justice programs, and bilingual services, notably in Spanish. WOAR employs evidence-based therapeutic approaches such as trauma-informed cognitive behavioral therapy and EMDR, and extends support to diverse communities including LGBTQIA+ and Latino populations. The organization engages in advocacy for legal reforms, community education, and justice alternatives, and partners with local government on safe nightlife certification programs. WOAR also provides specialized trainings for industries such as hospitality and entertainment to foster safe, inclusive environments. | Health Services |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Biomedical Advanced Research & Development Authority | |
National Center for Advancing Translational Sciences
National Center for Advancing Translational Sciences National AgencyGovernment National agency | Government |
Tunnell Government Services, Inc.
Tunnell Government Services, Inc. Miscellaneous Commercial ServicesCommercial Services Provides assistance for government agencies | Commercial Services |
AN2 Therapeutics, Inc.
AN2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale